Partner, Boston Consulting Group · Los Angeles
I help senior leaders across industries (especially in MedTech and BioPharma) set ambitious growth targets and translate them into executable strategy at the intersection of innovation, strategic judgment, and enterprise transformation.
I work with leadership teams to define credible long-term ambitions, build muscle for strategic foresight, prioritize competing strategic options, and build roadmaps that translate aspiration into execution.
I help organizations move from growth ambition to realized, enterprise-level impact by translating targets to executable programs and initiatives supported by a durable operating model to deliver value.
Deep expertise across life science tools, diagnostics, genomics, biopharma, medical devices, and health tech, grounded in a research background in translational biology.
I am a Partner at Boston Consulting Group, where I lead engagements in Corporate Finance & Strategy and Health Care. My work focuses on growth strategy, total shareholder return, innovation, and large-scale transformation — primarily with MedTech, BioPharma, and Life Sciences companies.
I am a co-author of BCG's Most Innovative Companies and Vitality reports and bring considerable expertise in digital health, molecular diagnostics, pharmacology, data analytics, deep tech, and commercialization.
Before joining BCG, I was a research fellow in pharmacology at Baylor College of Medicine and a founder and board member of Enventure, a non-profit connecting life science entrepreneurs with educational and networking resources.
I work with CEOs, boards, and senior leadership teams. If you're navigating a complex strategic decision in healthcare or life sciences, I'm glad to connect.